SyndromeNCT07576114
Comparison of Gluteal Muscle Activation and Core Strengthening in Dead Butt Syndrome Syndrome
A study testing Group A: Gluteal Muscle Activation and Group B: Gluteal Muscle Activation and Core stregthening exercises in people with Syndrome, run by Riphah International University at 1 site in Pakistan.
Trial summary
The study design would be a Randomized Controlled Trial.This study would include a total 40 participants. 20 participants in each group. Sample size is obtained through G-power. The study duration will be 12 months after the approval from the research board. Non-probability convenience sampling will be used. Read more about this study
- Who is it for?
- Ages 18 to 55 years
- Conditions the study is for
- Syndrome
- What is being tested?
- Group A: Gluteal Muscle Activation and Group B: Gluteal Muscle Activation and Core stregthening exercises
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 40 participants
- Where
- 1 sitePakistan
- Study dates
- 5 Dec 2025to 28 May 2026
- Phase
- Interventional
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 to 55 years
- All sexes
- No healthy volunteers
- Adult
Who may be able to join
- Symptoms persisting for more than 6 weeks (subacute or chronic cases).
- Sedentary to moderately active individuals (i.e., not involved in heavy gluteal-strengthening or core training for at least 3 months prior to the study). vParticipants will be diagnosed with Dead Butt Syndrome based on the presence of at least two out of three of the following criteria:
- Self-reported dull ache, discomfort, or tightness in the gluteal region worsened with prolonged sitting or walking.
- Positive Trendelenburg Test
- ≤ 4/5 on the standard MRC grading scale
Who cannot join
- Pregnancy or plans to become pregnant during the study period.
- Diagnosed hip labral tears, piriformis syndrome, or sciatica unrelated to gluteal amnesia.
- Degenerative or neurological conditions such as osteoarthritis, multiple sclerosis, stroke, or spinal cord injury.
- History of significant spinal trauma or surgery in the past 12 months.
- Engagement in regular physical exercise or participation in rehabilitation programs within the last 6 months.
Trial locations and contacts
1 site in 1 country. Contact the study team or a site near you to ask about taking part.
Pakistan1 site, 1 recruiting
- Recruiting
Riphah University Islamabad
Islamabad
Rehmat Khatoon, MS-OMPT, 0321-8562693, rehmi123jillani@gmail.com
Attiq ur Rehman, DPT, MS, 0336-1055533, attiq.rehman@riphah.edu.pk
About this study
Official title: Comparison of Gluteal Muscle Activation and Core Strengthening in Dead Butt Syndrome
The study design would be a Randomized Controlled Trial.This study would include a total 40 participants. 20 participants in each group. Sample size is obtained through G-power. The study duration will be 12 months after the approval from the research board. Non-probability convenience sampling will be used. Randomization will be done through sealed envelope method. The study will be conducted from Quaid-e-Azam Hospital Rawalpindi and Margalla Rehabilitation Centre.
- Conditions
- Syndrome
- Being tested
- Group A: Gluteal Muscle Activation, Group B: Gluteal Muscle Activation and Core stregthening exercises
- Keywords
- Dead Butt Syndrome, Gluteal Muscle Activation, Core Strengthening
- Medical subject headings
- Syndrome
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Group A: Gluteal Muscle ActivationOther
Gluteal Activation focuses on "waking up" and isolating the gluteus maximus, medius, and minimus to ensure they fire properly, often using low-load, high-control movements.
Group B: Gluteal Muscle Activation and Core stregthening exercisesOther
Gluteal Activation focuses on "waking up" and isolating the gluteus maximus, medius, and minimus to ensure they fire properly, often using low-load, high-control movements.Core Strengthening focuses on stabilizing the spine and pelvis by targeting the abdominals, back, and deep pelvic muscles.
| Study group | Role | What they receive |
|---|---|---|
| Group A: Gluteal Activation | Experimental | Not described Receives: Other: Group A: Gluteal Muscle Activation |
| Active comparator | Active comparator | Group B - Gluteal Muscle Activation Program + Core Strengthening Program Hot pack applied to lumbar area for 15-20 minutes. 3 sessions per week for 4 weeks. Moderate intensity, bodyweight-based exercises with controlled movement. Each exercise: 3 sets of 15 repetitions with 30-40 seconds rest between sets. Target: Gluteal muscles and pelvic control: Receives: Other: Group B: Gluteal Muscle Activation and Core stregthening exercises |
What is being measured
The primary outcome is the main question the study is designed to answer.
Tampa Scale of Kinesiophobia (TSK-11)
The Tampa Scale for Kinesiophobia (TSK-11) is a shortened, 11-item version of the original 17-item TSK questionnaire used to assess fear of movement, or kinesiophobia, in individuals with chronic pain or other conditions involving movement limitations
Measured: 4 weeks
Lower Extremity Functional Scale (LEFS)
The Lower Extremity Functional Scale (LEFS) is used to assess "patients' initial function, ongoing progress, and outcome" for a variety of disorders affecting the lower extremities. LEFS is a self-reported survey. The LEFS total score ranges from 0 to 80, with higher scores indicating better functional ability.
Measured: 4 weeks
Numeric Pain Rating Scale
The Numeric Pain Rating Scale (NPRS) is a tool used to measure the intensity of pain. It's a unidimensional scale, typically an 11-point scale ranging from 0 to 10, where 0 represents no pain and 10 represents the worst pain imaginable. Patients verbally or numerically indicate the level of pain they are experiencing.
Measured: 4 Weeks
The Trendelenburg test
The Trendelenburg test is a physical examination used to assess the strength of hip abductor muscles, specifically the gluteus medius and gluteus minimus, or to check for the competency of venous valves in the legs. A positive Trendelenburg sign, indicated by a drop of the pelvis on the unsupported side during a single-leg stance, suggests weakness in the hip abductors.
Measured: 4 Weeks
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted8 May 2026
- Study start5 Dec 2025
- Primary completion5 May 2026 (estimated)
- Study completion28 May 2026 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for SyndromeStudies of the same condition, open and under way.
- More trials run by Riphah International UniversityThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- None (open label)
- Enrolment
- 40 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Riphah International University
- Sponsor type
- University, hospital or other
- Responsible party
- Sponsor
- Investigators
- Attiq Ur Rehman, MS, Principal investigator, Riphah International University
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07576114
- Sponsor's protocol ID
- REC/02289 Rehmat
- Status last verified
- May 2026
- First submitted
- 4 May 2026
- Last updated
- 8 May 2026
- Results posted
- No
- Data monitoring committee
- Yes
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No
Study at a glance
From the registry record, last updated by the sponsor on 8 May 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Comparison of Gluteal Muscle Activation and Core Strengthening in Dead Butt Syndrome
- ClinicalTrials.gov ID
- NCT07576114
- Acronym / sponsor ID
- REC/02289 Rehmat
- Conditions
- Syndrome
- Keywords
- Dead Butt Syndrome, Gluteal Muscle Activation, Core Strengthening
- Study type
- Interventional
- Recruitment status
- Recruiting
- Enrolment
- 40 participants (estimated)
- Lead sponsor
- Riphah International UniversityUniversity, hospital or other
- Study start
- 5 Dec 2025 (actual)
- Primary completion
- 5 May 2026 (estimated)
- Study completion
- 28 May 2026 (estimated)
- First posted
- 8 May 2026 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The study design would be a Randomized Controlled Trial.This study would include a total 40 participants. 20 participants in each group. Sample size is obtained through G-power. The study duration will be 12 months after the approval from the research board. Non-probability convenience sampling will be used. Randomization will be done through sealed envelope method. The study will be conducted from Quaid-e-Azam Hospital Rawalpindi and Margalla Rehabilitation Centre.
Study design
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- None (open label)
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| Group A: Gluteal Activation | Experimental | Other: Group A: Gluteal Muscle Activation |
| Active comparator | Active comparator | Other: Group B: Gluteal Muscle Activation and Core stregthening exercisesGroup B - Gluteal Muscle Activation Program + Core Strengthening Program Hot pack applied to lumbar area for 15-20 minutes. 3 sessions per week for 4 weeks. Moderate intensity, bodyweight-based exercises with controlled movement. Each exercise: 3 sets of 15 repetitions with 30-40 seconds rest between sets. Target: Gluteal muscles and pelvic control: |
Who may qualify
- Ages
- 18 to 55 years
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult
Key inclusion criteria (5 listed)
- Symptoms persisting for more than 6 weeks (subacute or chronic cases).
- Sedentary to moderately active individuals (i.e., not involved in heavy gluteal-strengthening or core training for at least 3 months prior to the study). vParticipants will be diagnosed with Dead Butt Syndrome based on the presence of at least two out of three of the following criteria:
- Self-reported dull ache, discomfort, or tightness in the gluteal region worsened with prolonged sitting or walking.
- Positive Trendelenburg Test
- ≤ 4/5 on the standard MRC grading scale
Key exclusion criteria (5 listed)
- Pregnancy or plans to become pregnant during the study period.
- Diagnosed hip labral tears, piriformis syndrome, or sciatica unrelated to gluteal amnesia.
- Degenerative or neurological conditions such as osteoarthritis, multiple sclerosis, stroke, or spinal cord injury.
- History of significant spinal trauma or surgery in the past 12 months.
- Engagement in regular physical exercise or participation in rehabilitation programs within the last 6 months.
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Group A: Gluteal Muscle ActivationGluteal Activation focuses on "waking up" and isolating the gluteus maximus, medius, and minimus to ensure they fire properly, often using low-load, high-control movements. | Other | Group A: Gluteal Activation |
| Group B: Gluteal Muscle Activation and Core stregthening exercisesGluteal Activation focuses on "waking up" and isolating the gluteus maximus, medius, and minimus to ensure they fire properly, often using low-load, high-control movements.Core Strengthening focuses on stabilizing the spine and pelvis by targeting the abdominals, back, and deep pelvic muscles. | Other | Active comparator |
Primary outcome
Tampa Scale of Kinesiophobia (TSK-11)
Time frame: 4 weeks
The Tampa Scale for Kinesiophobia (TSK-11) is a shortened, 11-item version of the original 17-item TSK questionnaire used to assess fear of movement, or kinesiophobia, in individuals with chronic pain or other conditions involving movement limitations
Lower Extremity Functional Scale (LEFS)
Time frame: 4 weeks
The Lower Extremity Functional Scale (LEFS) is used to assess "patients' initial function, ongoing progress, and outcome" for a variety of disorders affecting the lower extremities. LEFS is a self-reported survey. The LEFS total score ranges from 0 to 80, with higher scores indicating better functional ability.
Numeric Pain Rating Scale
Time frame: 4 Weeks
The Numeric Pain Rating Scale (NPRS) is a tool used to measure the intensity of pain. It's a unidimensional scale, typically an 11-point scale ranging from 0 to 10, where 0 represents no pain and 10 represents the worst pain imaginable. Patients verbally or numerically indicate the level of pain they are experiencing.
The Trendelenburg test
Time frame: 4 Weeks
The Trendelenburg test is a physical examination used to assess the strength of hip abductor muscles, specifically the gluteus medius and gluteus minimus, or to check for the competency of venous valves in the legs. A positive Trendelenburg sign, indicated by a drop of the pelvis on the unsupported side during a single-leg stance, suggests weakness in the hip abductors.
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 8 May 2026.
- Individual participant dataSharing planned: No
Related trials for Syndrome
Active, not recruitingPhase 1/2
Selumetinib in Treating Young Patients With Recurrent or Refractory Low Grade Glioma
Low Grade Glioma, Recurrent Childhood Pilocytic Astrocytoma
Not yet recruitingPhase 1
Phase I Open-Label Safety Trial of Pembrolizumab for Neurological Post- Acute Sequelae of SARS-CoV-2 (PD1-PASC I)
Post-Acute COVID-19 Syndrome
Not yet recruitingPhase 2/3
A Pivotal Safety and Immunogenicity GBS-NN/NN2 Vaccine Maternal Immunisation Trial
Streptococcus Agalactiae Infection, Neonatal Sepsis
RecruitingPhase 1
Serial Amnioinfusions as Regenerative Therapy for Pulmonary Hypoplasia
Renal Failure Congenital, Congenital Renal Anomaly Nos
Not yet recruiting
HealthMpowerment Korea: Pilot Testing the Cultural Adaptation of a Digital HIV Intervention for Men Who Have Sex With Men in South Korea
HIV Infections, HIV Prevention and Care
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part.
Attiq Ur Rehman, MS principal investigator
Riphah International University
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Group A: Gluteal Muscle Activation and Group B: Gluteal Muscle Activation and Core stregthening exercises in people with Syndrome, run by Riphah International University at 1 site in Pakistan.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 5 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: looking for participants now, as of the sponsor's last update on 8 May 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Pakistan. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
Contact REHMAT KHATOON, MS-OMPT (0321-8562693, rehmi123jillani@gmail.com), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Tampa Scale of Kinesiophobia (TSK-11) (time frame: 4 weeks). The study lists 4 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 8 May 2026.